MedPath

Swasakudori maathirai for Childhood Asthma

Phase 3
Not yet recruiting
Conditions
Mild intermittent asthma,
Registration Number
CTRI/2019/12/022527
Lead Sponsor
National institute of Siddha
Brief Summary

It is an Interventional study in which 10 childrenwith symptoms like cough ,wheezing ,Tightness of chest will be selected based on inclusion and exclusion criteria.After enrolling the patients in the study Swasakudori Maathirai 45 mg or 65 mg will be given twice  a day for 45 days.After 45 days patient wil be sked to absence of clinical signs and symptoms of childhood Asthma

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Cough,Wheezing,Tightness of chest,Shortness of breath,Abdominal bloating,Loss of appetite.

Exclusion Criteria

Haemoptysis,Active Primary complex,Congenital Heart diseases,Pneumonia, Any other serious illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of the trial drug is measured by peak expiratory flow meterFourty Sixth day
Secondary Outcome Measures
NameTimeMethod
Reduction in the recurrence of the disease and improvement in the quality of life of childrenImprovement in clinical symptoms

Trial Locations

Locations (1)

Ayothidoss Pandithar Hospital,National Institute of Siddha

🇮🇳

Kancheepuram, TAMIL NADU, India

Ayothidoss Pandithar Hospital,National Institute of Siddha
🇮🇳Kancheepuram, TAMIL NADU, India
Dr C Srinivasan
Principal investigator
7639712589
Csrinivas7639@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.